GJB2 and ERO1LB levels were shown to have prognostic significance and therapeutic strategies targeting GJB2 and facilitating ERO1LB expression may deserve evaluation to improve prognosis of pancreatic cancer patients. The gene discussed is ERO1B; the disease is pancreatic neoplasm.